Status:

COMPLETED

Transcranial Direct Current Stimulation (tDCS) in Human Subjects With PTSD Receiving an Exposure-based, Behavioral Therapy

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Conditions:

Post Traumatic Stress Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The primary objective of this study is to evaluate the safety, feasibility, and psychological and physiological treatment benefits of transcranial direct current stimulation (tDCS), a noninvasive brai...

Detailed Description

While the potential for non-invasive brain stimulation is exciting, research is needed to determine the safety, feasibility, and benefits of non-invasive brain stimulation in human subjects with PTSD....

Eligibility Criteria

Inclusion

  • Individuals between the ages of 18 and 65 years old at time of screening.
  • PTSD diagnosis as assessed by the Clinician-Administered Posttraumatic Stress Scale (CAPS-5)
  • Able to write, read, and speak English

Exclusion

  • History of epilepsy or seizures.
  • History of significant intracranial pathology (e.g., severe traumatic brain injury) or neurological disorder (e.g., Stroke, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's, Dementia, Parkinson's, and/or Huntington's).
  • History of skin condition (e.g., eczema, psoriasis) where electrodes will be applied.
  • Electronic implants in the body that could be susceptible to electrical current (e.g., cardiac pacemaker, cochlear implants, medical pump).
  • Metallic objects other than dental appliances/fillings near the site of stimulation
  • Current manic episode or psychotic symptoms requiring immediate stabilization or hospitalization (as determined by clinical judgement).
  • Current moderate or severe substance use disorder.
  • Suicidality and/or psychiatric risk requiring immediate intervention or a higher level of care than can be provided by the study treatment.
  • Change in anticonvulsive or benzodiazepine medication regimen in the past month.
  • History of adverse effects to previous tDCS or other brain stimulation technique.
  • Concurrent engagement in another brain simulation technique or trauma-related psychotherapy for PTSD.
  • Currently pregnant or breastfeeding.

Key Trial Info

Start Date :

January 9 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 25 2024

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT05419999

Start Date

January 9 2023

End Date

April 25 2024

Last Update

May 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229